Is TB-500 the same as thymosin beta-4?

The Chemical Distinction

Thymosin beta-4 (Tβ4) is a naturally occurring 43-amino-acid protein present in nearly all mammalian cells. It plays roles in cell migration, angiogenesis, wound healing, and anti-inflammatory processes.

"TB-500" is a marketing term for synthetic peptide preparations that typically contain the biologically active fragment of thymosin beta-4 — most commonly the LKKTET sequence (residues 17–23) or slightly longer fragments around the central active domain.

Why the Fragment vs Full-Length Matters

Advantages of the fragment (TB-500)

• Cheaper to synthesize
• More stable in solution
• Retains most biological activity
• Easier to scale in compounding

Potential disadvantages

• May lack some secondary effects of full-length thymosin beta-4
• Slightly different pharmacokinetics
• Not identical to endogenous Tβ4

Which Form Is in Your Vial?

Here's where it gets muddy. Commercial "TB-500" preparations vary:

• Most compounded TB-500: N-acetylated synthetic fragment (typically 17-mer)
• Research-grade "thymosin beta-4": may be full 43-amino-acid sequence
• Hybrid preparations: some compounders use longer fragments marketed as either name

The label on your vial doesn't always specify. This is a quality control gap in the compounded peptide market.

Does the Difference Matter Clinically?

Practically, for typical use cases (tissue healing, tendon repair, muscle recovery):

• Fragment and full-length produce similar outcomes in most reported clinical experience
• Dose adjustments may be needed if switching between forms (full-length often requires higher doses for equivalent effect)
• Most research data reference the fragment or "TB-500" as marketed

Why Two Names Exist

Historical development

• Thymosin beta-4 was isolated and characterized in the 1970s
• Pharmaceutical development (RegeneRx) took it through clinical trials for wound healing and cardiac indications
• Synthetic fragment ("TB-500") emerged in veterinary applications, particularly for racehorses
• The fragment became popular in human off-label use due to lower cost and easier compounding

Naming conventions

• "Thymosin beta-4" or "Tβ4" typically refers to the full-length natural peptide
• "TB-500" is more often associated with the synthetic fragment
• Not universally observed — some practitioners use the names interchangeably

Research Evidence

Full-length thymosin beta-4 research

• RegeneRx conducted Phase 2 and Phase 3 trials for dry eye disease (partially positive)
• Cardiac repair studies with full Tβ4 showed modest benefits in animal models
• Wound healing trials in humans for venous stasis ulcers

TB-500 fragment research

• Primarily animal studies on tissue repair
• Equine/veterinary case series
• Limited human case reports

Does It Matter for Your Purchase Decision?

Practical guidance when buying compounded TB-500:

• Verify the pharmacy can tell you exactly what sequence is in the vial
• Certificate of Analysis should specify sequence and purity
• Both forms appear to work for typical healing applications
• Don't pay a premium for "full-length thymosin beta-4" unless you have a specific reason

Dosing Differences

Accounting for molecular weight differences:

• Full Tβ4: ~5 kDa, dose typically higher
• TB-500 fragment: ~800 Da, smaller molecule
• In commercial "TB-500" at 5 mg vial, you're getting roughly 5–6× the molar amount compared to equivalent mg of full-length protein

For most users this distinction isn't meaningful because both forms are dosed by mg based on clinical experience, not molar calculations.

Regulatory Status

• Neither full thymosin beta-4 nor TB-500 fragment is FDA-approved for any indication
• Both are compounded preparations
• Clinical trials for specific indications (wound healing, dry eye) have been completed without approval

WADA Status

Both forms are on the World Anti-Doping Agency prohibited list. Competitive athletes should not use either form.

Bottom Line

"TB-500" in most commercial compounded vials is a synthetic fragment of the full 43-amino-acid thymosin beta-4 protein. The fragment retains most biological activity and is what most research and clinical experience references. For typical users pursuing tissue healing, the naming distinction matters less than pharmacy quality, dose accuracy, and compounding practices. Verify what you're buying via Certificate of Analysis.

See the TB-500 guide. Related: vs BPC-157, cost per vial.